Rankings
▼
Calendar
APGE Q2 2024 Earnings — Apogee Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
APGE
Apogee Therapeutics, Inc.
$4B
Q2 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$44M
Net Income
-$34M
EPS (Diluted)
$-0.60
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$29M
Free Cash Flow
-$29M
Stock-Based Comp.
$6M
Balance Sheet
Total Assets
$801M
Total Liabilities
$27M
Stockholders' Equity
$774M
Cash & Equivalents
$307M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
$0
—
Operating Income
-$44M
-$19M
-133.6%
Net Income
-$34M
-$19M
-79.1%
← FY 2024
All Quarters
Q3 2024 →